DIVA Laboratories Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
DIVA Laboratories has a total shareholder equity of NT$1.0B and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$1.3B and NT$319.3M respectively. DIVA Laboratories's EBIT is NT$113.0M making its interest coverage ratio -20.9. It has cash and short-term investments of NT$607.7M.
Belangrijke informatie
0%
Verhouding schuld/eigen vermogen
NT$0
Schuld
| Rente dekkingsratio | -20.9x |
| Contant | NT$607.65m |
| Aandelen | NT$1.02b |
| Totaal verplichtingen | NT$319.35m |
| Totaal activa | NT$1.34b |
Recente financiële gezondheidsupdates
Geen updates
Analyse van de financiële positie
Kortlopende schulden: 4153's short term assets (NT$1.1B) exceed its short term liabilities (NT$314.8M).
Langlopende schulden: 4153's short term assets (NT$1.1B) exceed its long term liabilities (NT$4.5M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 4153 is debt free.
Schuld verminderen: 4153 had no debt 5 years ago.
Schuldendekking: 4153 has no debt, therefore it does not need to be covered by operating cash flow.
Rentedekking: 4153 has no debt, therefore coverage of interest payments is not a concern.